125 related articles for article (PubMed ID: 14734478)
1. Chemosensitization of androgen-independent prostate cancer with neutral endopeptidase.
Sumitomo M; Asano T; Asakuma J; Asano T; Nanus DM; Hayakawa M
Clin Cancer Res; 2004 Jan; 10(1 Pt 1):260-6. PubMed ID: 14734478
[TBL] [Abstract][Full Text] [Related]
2. Neutral endopeptidase promotes phorbol ester-induced apoptosis in prostate cancer cells by inhibiting neuropeptide-induced protein kinase C delta degradation.
Sumitomo M; Shen R; Goldberg JS; Dai J; Navarro D; Nanus DM
Cancer Res; 2000 Dec; 60(23):6590-6. PubMed ID: 11118039
[TBL] [Abstract][Full Text] [Related]
3. Protein kinase Cdelta amplifies ceramide formation via mitochondrial signaling in prostate cancer cells.
Sumitomo M; Ohba M; Asakuma J; Asano T; Kuroki T; Asano T; Hayakawa M
J Clin Invest; 2002 Mar; 109(6):827-36. PubMed ID: 11901191
[TBL] [Abstract][Full Text] [Related]
4. Neutral endopeptidase inhibits prostate cancer cell migration by blocking focal adhesion kinase signaling.
Sumitomo M; Shen R; Walburg M; Dai J; Geng Y; Navarro D; Boileau G; Papandreou CN; Giancotti FG; Knudsen B; Nanus DM
J Clin Invest; 2000 Dec; 106(11):1399-407. PubMed ID: 11104793
[TBL] [Abstract][Full Text] [Related]
5. Androgen-induced growth inhibition of androgen receptor expressing androgen-independent prostate cancer cells is mediated by increased levels of neutral endopeptidase.
Shen R; Sumitomo M; Dai J; Harris A; Kaminetzky D; Gao M; Burnstein KL; Nanus DM
Endocrinology; 2000 May; 141(5):1699-704. PubMed ID: 10803579
[TBL] [Abstract][Full Text] [Related]
6. Neutral endopeptidase 24.11 loss in metastatic human prostate cancer contributes to androgen-independent progression.
Papandreou CN; Usmani B; Geng Y; Bogenrieder T; Freeman R; Wilk S; Finstad CL; Reuter VE; Powell CT; Scheinberg D; Magill C; Scher HI; Albino AP; Nanus DM
Nat Med; 1998 Jan; 4(1):50-7. PubMed ID: 9427606
[TBL] [Abstract][Full Text] [Related]
7. Tumor-suppressive effects of neutral endopeptidase in androgen-independent prostate cancer cells.
Dai J; Shen R; Sumitomo M; Goldberg JS; Geng Y; Navarro D; Xu S; Koutcher JA; Garzotto M; Powell CT; Nanus DM
Clin Cancer Res; 2001 May; 7(5):1370-7. PubMed ID: 11350908
[TBL] [Abstract][Full Text] [Related]
8. Methylation of the neutral endopeptidase gene promoter in human prostate cancers.
Usmani BA; Shen R; Janeczko M; Papandreou CN; Lee WH; Nelson WG; Nelson JB; Nanus DM
Clin Cancer Res; 2000 May; 6(5):1664-70. PubMed ID: 10815884
[TBL] [Abstract][Full Text] [Related]
9. Corn silk maysin induces apoptotic cell death in PC-3 prostate cancer cells via mitochondria-dependent pathway.
Lee J; Lee S; Kim SL; Choi JW; Seo JY; Choi DJ; Park YI
Life Sci; 2014 Dec; 119(1-2):47-55. PubMed ID: 25445226
[TBL] [Abstract][Full Text] [Related]
10. Involvement of protein kinase C delta (PKCdelta) in phorbol ester-induced apoptosis in LNCaP prostate cancer cells. Lack of proteolytic cleavage of PKCdelta.
Fujii T; García-Bermejo ML; Bernabó JL; Caamaño J; Ohba M; Kuroki T; Li L; Yuspa SH; Kazanietz MG
J Biol Chem; 2000 Mar; 275(11):7574-82. PubMed ID: 10713064
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of neutral endopeptidase-24.11 (neprilysin) and endothelin-converting enzyme in human prostate cancer cell lines.
Usmani BA; Harden B; Maitland NJ; Turner AJ
Clin Sci (Lond); 2002 Aug; 103 Suppl 48():314S-317S. PubMed ID: 12193112
[TBL] [Abstract][Full Text] [Related]
12. Cell specific expression of CD10/neutral endopeptidase 24.11 gene in human prostatic tissue and cells.
Song J; Aumüller G; Xiao F; Wilhelm B; Albrecht M
Prostate; 2004 Mar; 58(4):394-405. PubMed ID: 14968440
[TBL] [Abstract][Full Text] [Related]
13. Protein kinase C delta is essential for etoposide-induced apoptosis in salivary gland acinar cells.
Reyland ME; Anderson SM; Matassa AA; Barzen KA; Quissell DO
J Biol Chem; 1999 Jul; 274(27):19115-23. PubMed ID: 10383415
[TBL] [Abstract][Full Text] [Related]
14. Novel combination therapy against metastatic and androgen-independent prostate cancer by using gefitinib, tamoxifen and etoposide.
Mimeault M; Venkatraman G; Johansson SL; Moore E; Henichart JP; Depreux P; Lin MF; Batra SK
Int J Cancer; 2007 Jan; 120(1):160-9. PubMed ID: 17013895
[TBL] [Abstract][Full Text] [Related]
15. Neutral endopeptidase inhibits neuropeptide-mediated transactivation of the insulin-like growth factor receptor-Akt cell survival pathway.
Sumitomo M; Milowsky MI; Shen R; Navarro D; Dai J; Asano T; Hayakawa M; Nanus DM
Cancer Res; 2001 Apr; 61(8):3294-8. PubMed ID: 11309283
[TBL] [Abstract][Full Text] [Related]
16. Protein kinase Calpha and protein kinase Cdelta play opposite roles in the proliferation and apoptosis of glioma cells.
Mandil R; Ashkenazi E; Blass M; Kronfeld I; Kazimirsky G; Rosenthal G; Umansky F; Lorenzo PS; Blumberg PM; Brodie C
Cancer Res; 2001 Jun; 61(11):4612-9. PubMed ID: 11389098
[TBL] [Abstract][Full Text] [Related]
17. Expression and immunolocalisation of neutral endopeptidase in prostate cancer.
Albrecht M; Mittler A; Wilhelm B; Lundwall A; Lilja H; Aumüller G; Bjartell A
Eur Urol; 2003 Oct; 44(4):415-22. PubMed ID: 14499674
[TBL] [Abstract][Full Text] [Related]
18. Drug resistance in prostate cancer cell lines is influenced by androgen dependence and p53 status.
Serafin AM; Akudugu JM; Bohm L
Urol Res; 2002 Oct; 30(5):289-94. PubMed ID: 12389116
[TBL] [Abstract][Full Text] [Related]
19. Targeting protein kinase C (PKC) and telomerase by phenethyl isothiocyanate (PEITC) sensitizes PC-3 cells towards chemotherapeutic drug-induced apoptosis.
Mukherjee S; Bhattacharya RK; Roy M
J Environ Pathol Toxicol Oncol; 2009; 28(4):269-82. PubMed ID: 20102325
[TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of two androgen response regions in the human neutral endopeptidase gene.
Shen R; Sumitomo M; Dai J; Hardy DO; Navarro D; Usmani B; Papandreou CN; Hersh LB; Shipp MA; Freedman LP; Nanus DM
Mol Cell Endocrinol; 2000 Dec; 170(1-2):131-42. PubMed ID: 11162897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
